CompletedPhase 2NCT01390350
Ilaris® Effects in Schnitzler Syndrome (ILESCH)
Studying Schnitzler syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Charite University, Berlin, Germany
- Principal Investigator
- Karoline Krause, MDCharité University, Berlin
- Intervention
- Canakinumab(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2018
Study locations (5)
- Allergie-Centrum-Charité, Charité University, Berlin, Germany
- Dept. of Dermatology, Klinikum Darmstadt, Darmstadt, Germany
- Dept. of Dermatology, University Heidelberg, Heidelberg, Germany
- Dept. of Dermatology, University Münster, Münster, Germany
- Dept. of Dermatology, University Tübingen, Tübingen, Germany
Collaborators
Novartis Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01390350 on ClinicalTrials.gov